4/8/2013

An analysis of data from a health database in Taiwan found that men who took the antiarrhythmia drug amiodarone had a nearly 20% increased risk of developing cancer compared with the general population. The risk was 46% greater among men with extensive exposure to the drug. Women, however, did not seem to have a higher risk, researchers reported in the journal Cancer.

Related Summaries